Collaborative Care

04/03/2014 - 8:55am

MannKind Corp. on Tuesday announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration voted 13-to-1 to recommend that Afrezza (insulin human [rDNA origin]) inhalation powder be granted marketing approval by the FDA to improve glycemic control in adults with Type 1 diabetes and voted 14-to-0 to recommend that Afrezza be granted marketing approval by the FDA to improve glycemic control in adults with Type 2 diabetes.

04/03/2014 - 6:58am

Axium Healthcare Pharmacy announced that it will begin to dispense Otezla, the new oral therapy for the treatment of adults with active psoriatic arthritis.

04/02/2014 - 4:01pm

Labeed Diab has been named SVP and president health and wellness at Walmart, filling a position previously held by Dr. John Agwunobi, who left the company.

04/02/2014 - 2:55pm

Access to good and affordable health care is the No. 1 concern of Americans today, trumping national security, national debt, improving the quality of education, gun violence and protecting privacy rights, according to a survey recently conducted for the National Commission on Certification of Physician Assistants.

04/02/2014 - 1:45pm

Stayhealthy announced the completion of its deployment of Stayhealthy HealthCENTER Kiosks in six states throughout the Supervalu chain of supermarkets and pharmacies.

04/02/2014 - 1:38pm

Publix and Walgreens have partnered with a local coalition to collect expired medications, according to a report in the Delray Beach newspaper the Pineapple published Monday.

04/02/2014 - 11:29am

Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.

04/02/2014 - 11:28am

Sandoz on Tuesday announced the U.S. market introduction of its calcipotriene and betamethasone dipropionate ointment, the first generic version of Leo Pharma’s Taclonex Ointment.

04/02/2014 - 10:56am

AZO Products, a urinary and vaginal health brand for women, announced the launch of AZO Bladder Control with Go-Less. The product serves as a supplement to prescriptions and over-the-counter options and helps optimize normal bladder activity and bladder strength, the company said.

© 2014 Drug Store News. All Rights Reserved.